+39 02 610346.1 - info@newron.com

Latest press releases

  • 12Sep
    Newron reports half-year 2019 results


  • 10Jul
    Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada


  • 28Jun
    Newron Receives First Tranche from Financing Agreement with European Investment Bank (EIB)


  • 27Jun
    Newron Pharmaceuticals now also listed on the primary market of the Düsseldorf Stock Exchange and on XETRA


  • 13Jun
    Newron Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

  • 28May
    Newron Pharmaceuticals provides update on regulatory status of evenamide for the treatment of schizophrenia


View All

Newron share price


  • 18Sep
    Investora Zürich 2019

    September 18-19, 2019 - Samsung Hall, Dübendorf, Switzerland

  • 8Sep
    21st Annual Healthcare Conference, sponsored by H.C. Wainwright

    September 8-10, 2019 - The Lotte New York Palace Hotel, New York, USA

  • 19Jun
    JMP Securities Life Sciences Conference

    June 19-20, 2019 - The St. Regis New York, New York City, USA

View Event Calendar